Skip to main content
Erschienen in: Infection 2/2015

01.04.2015 | Original Paper

Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS)

verfasst von: F. Maechler, L. A. Peña Diaz, C. Schröder, C. Geffers, M. Behnke, P. Gastmeier

Erschienen in: Infection | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Standardized prevalence and incidence data on carbapenem-resistant organisms (CRO) and, as a relevant subgroup, carbapenem-resistant Enterobacteriaceae (CRE) are scarce. CRO-surveillance within the German nosocomial infection surveillance system (KISS) aims to provide epidemiological surveillance data on CRO colonizations and infections.

Methods

CRO-surveillance is part of a KISS-module for the surveillance of multidrug-resistant organisms (MDRO). MDRO-KISS methods require surveillance of all patients admitted to the ward and standardized documentation of imported and ICU-acquired cases. Data on all MDRO-carriers including colonization and infection with MDRO are collected. All presented data were routine data collected from January 1st 2013 until December 1st 2013 in accordance with the German Protection against Infection Act (IfSG).

Results

341 ICUs submitted data on MDRO during the first year. In total, 5,171 cases of multidrug-resistant Gram-negative bacteria (MRGN) were identified. 848 were CRO (16 %). 325 CRO-cases were acquired within the ICU (38 %), and 373 CRO-patients had an infection (44 %). CRO-prevalence was 0.29 per 100 patients. Acquisition rate of MRGN was 1.32 per 1,000 patient days. This rate is more than doubled the acquisition rates of other MDRO under surveillance within MDRO-KISS (0.57 MRSA, 0.49 VRE). CRO-acquisition rate was 0.3 per 1,000 patient days. Incidence density of MRGN infections bacteria was 0.58 per 1,000 patient days (CRO 0.15/1,000 patient days).

Conclusions

To date, CRO are common in German ICUs and the relatively large proportions of ICU-acquired CRO and infections emphasize their potential to cause outbreaks. High MRGN infection rates and high ESBL prevalence data from clinical studies suggest a lack of MRGN identification in asymptomatic carriers.
Literatur
1.
Zurück zum Zitat Antimicrobial resistance: global report on surveillance 2014. World Health Organization; 2014 Antimicrobial resistance: global report on surveillance 2014. World Health Organization; 2014
3.
Zurück zum Zitat Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho, F et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med. 2012;38:1930–45. doi:10.1007/s00134-012-2695-9. Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho, F et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med. 2012;38:1930–45. doi:10.​1007/​s00134-012-2695-9.
4.
Zurück zum Zitat Lubbert C, Becker-Rux D, Rodloff AC, Laudi S, Busch T, Bartels M, et al. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection. 2014;42:309–16. doi:10.1007/s15010-013-0547-3.CrossRefPubMed Lubbert C, Becker-Rux D, Rodloff AC, Laudi S, Busch T, Bartels M, et al. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection. 2014;42:309–16. doi:10.​1007/​s15010-013-0547-3.CrossRefPubMed
7.
Zurück zum Zitat KRINKO. Kommission für Krankenhaushygiene und Infektionsprävention: hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen. Bundesgesundheitsbl. 2012;55:1311–54.CrossRef KRINKO. Kommission für Krankenhaushygiene und Infektionsprävention: hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen. Bundesgesundheitsbl. 2012;55:1311–54.CrossRef
8.
Zurück zum Zitat Infektionsschutzgesetz vom 20. Juli 2000 (BGBl. I S. 1045), das durch Artikel 5 Absatz 2 des Gesetzes vom 20. April 2013 (BGBl. I S. 868) geändert worden ist, Artikel 5 Absatz 2 (2000). Infektionsschutzgesetz vom 20. Juli 2000 (BGBl. I S. 1045), das durch Artikel 5 Absatz 2 des Gesetzes vom 20. April 2013 (BGBl. I S. 868) geändert worden ist, Artikel 5 Absatz 2 (2000).
9.
Zurück zum Zitat Meyer E, Schroder C, Gastmeier P, Geffers C. The reduction of nosocomial MRSA infection in Germany: an analysis of data from the Hospital Infection Surveillance System (KISS) between 2007 and 2012. Deutsches Arzteblatt int. 2014;111:331–6. doi:10.3238/arztebl.2014.0331. Meyer E, Schroder C, Gastmeier P, Geffers C. The reduction of nosocomial MRSA infection in Germany: an analysis of data from the Hospital Infection Surveillance System (KISS) between 2007 and 2012. Deutsches Arzteblatt int. 2014;111:331–6. doi:10.​3238/​arztebl.​2014.​0331.
11.
Zurück zum Zitat Marquez P, Terashita D, Dassey D, Mascola L. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol. 2013;34:144–50. doi:10.1086/669087.CrossRefPubMed Marquez P, Terashita D, Dassey D, Mascola L. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol. 2013;34:144–50. doi:10.​1086/​669087.CrossRefPubMed
13.
Zurück zum Zitat Biehl LM, Schmidt-Hieber M, Liss B, Cornely OA, Vehreschild MJ. Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients—review of the literature from a clinical perspective. Crit Rev Microbiol. 2014;. doi:10.3109/1040841X.2013.875515.PubMed Biehl LM, Schmidt-Hieber M, Liss B, Cornely OA, Vehreschild MJ. Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients—review of the literature from a clinical perspective. Crit Rev Microbiol. 2014;. doi:10.​3109/​1040841X.​2013.​875515.PubMed
14.
Zurück zum Zitat Liss B, Vehreschild J, Cornely O, Hallek M, Fätkenheuer G, Wisplinghoff H, et al. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 2012;40:613–9.CrossRefPubMed Liss B, Vehreschild J, Cornely O, Hallek M, Fätkenheuer G, Wisplinghoff H, et al. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 2012;40:613–9.CrossRefPubMed
15.
Zurück zum Zitat Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, et al. Screening for extended-spectrum β-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis. 2007;45:846–52.CrossRefPubMed Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, et al. Screening for extended-spectrum β-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis. 2007;45:846–52.CrossRefPubMed
16.
Zurück zum Zitat Ehrhard I, Karaalp AK, Hackel T, Holl G, Rodewald N, Reif U, et al. Prevalence of carbapenemase-producing bacteria in hospitals in Saxony, Germany. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2014;57:406–13. doi:10.1007/s00103-013-1914-z.CrossRefPubMed Ehrhard I, Karaalp AK, Hackel T, Holl G, Rodewald N, Reif U, et al. Prevalence of carbapenemase-producing bacteria in hospitals in Saxony, Germany. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2014;57:406–13. doi:10.​1007/​s00103-013-1914-z.CrossRefPubMed
17.
Zurück zum Zitat Heudorf U, Gustav C, Mischler D, Schulze J. Healthcare associated infections (HAI), antibiotic use and prevalence of multidrug-resistant bacteria (MDRO) in residents of long-term care facilities: the Frankfurt HALT plus MDRO project 2012. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2014;57:414–22. doi:10.1007/s00103-013-1927-7.CrossRefPubMed Heudorf U, Gustav C, Mischler D, Schulze J. Healthcare associated infections (HAI), antibiotic use and prevalence of multidrug-resistant bacteria (MDRO) in residents of long-term care facilities: the Frankfurt HALT plus MDRO project 2012. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2014;57:414–22. doi:10.​1007/​s00103-013-1927-7.CrossRefPubMed
19.
Zurück zum Zitat Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro surveillance. 2008;13:19045.PubMed Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro surveillance. 2008;13:19045.PubMed
20.
Zurück zum Zitat Hombach M, Mouttet B, Bloemberg GV. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC beta-lactamase-producing clinical Enterobacteriaceae isolates. J Antimicrobiol Chemother. 2013;68:2092–8. doi:10.1093/jac/dkt136.CrossRef Hombach M, Mouttet B, Bloemberg GV. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC beta-lactamase-producing clinical Enterobacteriaceae isolates. J Antimicrobiol Chemother. 2013;68:2092–8. doi:10.​1093/​jac/​dkt136.CrossRef
22.
Zurück zum Zitat Kaase M, Anders A, Pfennigwerth N, Gatermann S. Report of the national reference laboratory for multidrug-resistant gramnegative bacteria on carbapenemases in Germany in 2013. ECCMID; Barcelona 2014. Kaase M, Anders A, Pfennigwerth N, Gatermann S. Report of the national reference laboratory for multidrug-resistant gramnegative bacteria on carbapenemases in Germany in 2013. ECCMID; Barcelona 2014.
23.
Zurück zum Zitat Maechler F, Schwab F, Geffers C, Gropmann A, Gastmeier P. Infection control policies and ICU-acquired ESBL-cases in Germany: a cross-sectional questionnaire survey of 224 ICUs. ECCMID; Barcelona 2014. Maechler F, Schwab F, Geffers C, Gropmann A, Gastmeier P. Infection control policies and ICU-acquired ESBL-cases in Germany: a cross-sectional questionnaire survey of 224 ICUs. ECCMID; Barcelona 2014.
25.
Zurück zum Zitat Zuschneid I, Rucker G, Schoop R, Beyersmann J, Schumacher M, Geffers C, et al. Representativeness of the surveillance data in the intensive care unit component of the German nosocomial infections surveillance system. Infect Control Hosp Epidemiol. 2010;31:934–8. doi:10.1086/655462.CrossRefPubMed Zuschneid I, Rucker G, Schoop R, Beyersmann J, Schumacher M, Geffers C, et al. Representativeness of the surveillance data in the intensive care unit component of the German nosocomial infections surveillance system. Infect Control Hosp Epidemiol. 2010;31:934–8. doi:10.​1086/​655462.CrossRefPubMed
Metadaten
Titel
Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS)
verfasst von
F. Maechler
L. A. Peña Diaz
C. Schröder
C. Geffers
M. Behnke
P. Gastmeier
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 2/2015
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0701-6

Weitere Artikel der Ausgabe 2/2015

Infection 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.